Durand SC - Search Results

1

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.

Colpitts CC, Tawar RG, Mailly L, Thumann C, Heydmann L, Durand SC, Xiao F, Robinet E, Pessaux P, Zeisel MB, Baumert TF. Colpitts CC, et al. Among authors: durand sc. Gut. 2018 Apr;67(4):736-745. doi: 10.1136/gutjnl-2016-312577. Epub 2017 Mar 30. Gut. 2018. PMID: 28360099 Free PMC article.

2

HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.

Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, Florentin J, Tawar RG, Xiao F, Turek M, Durand SC, Duong FH, Heim MH, Cosset FL, Hirsch I, Samuel D, Brino L, Zeisel MB, Le Naour F, McKeating JA, Baumert TF. Zona L, et al. Among authors: durand sc. Cell Host Microbe. 2013 Mar 13;13(3):302-13. doi: 10.1016/j.chom.2013.02.006. Cell Host Microbe. 2013. PMID: 23498955 Free article.

3

Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.

Lupberger J, Duong FH, Fofana I, Zona L, Xiao F, Thumann C, Durand SC, Pessaux P, Zeisel MB, Heim MH, Baumert TF. Lupberger J, et al. Among authors: durand sc. Hepatology. 2013 Oct;58(4):1225-35. doi: 10.1002/hep.26404. Epub 2013 Sep 5. Hepatology. 2013. PMID: 23519785

4

Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.

Fofana I, Zona L, Thumann C, Heydmann L, Durand SC, Lupberger J, Blum HE, Pessaux P, Gondeau C, Reynolds GM, McKeating JA, Grunert F, Thompson J, Zeisel MB, Baumert TF. Fofana I, et al. Among authors: durand sc. J Virol. 2013 Sep;87(18):10405-10. doi: 10.1128/JVI.01691-13. Epub 2013 Jul 17. J Virol. 2013. PMID: 23864633 Free PMC article.

5

In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.

Leboeuf C, Mailly L, Wu T, Bour G, Durand S, Brignon N, Ferrand C, Borg C, Tiberghien P, Thimme R, Pessaux P, Marescaux J, Baumert TF, Robinet E. Leboeuf C, et al. Mol Ther. 2014 Mar;22(3):634-644. doi: 10.1038/mt.2013.277. Epub 2013 Dec 6. Mol Ther. 2014. PMID: 24445938 Free PMC article.

6

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies.

Duong FH, Trincucci G, Boldanova T, Calabrese D, Campana B, Krol I, Durand SC, Heydmann L, Zeisel MB, Baumert TF, Heim MH. Duong FH, et al. Among authors: durand sc. J Exp Med. 2014 May 5;211(5):857-68. doi: 10.1084/jem.20131557. Epub 2014 Apr 21. J Exp Med. 2014. PMID: 24752298 Free PMC article.

7

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

Leboeuf C, Roser-Schilder J, Lambotin M, Durand S, Wu T, Fauvelle C, Su B, Bôle-Richard E, Deschamps M, Ferrand C, Tiberghien P, Pessaux P, Baumert TF, Robinet E. Leboeuf C, et al. Gene Ther. 2015 Feb;22(2):172-80. doi: 10.1038/gt.2014.99. Epub 2014 Nov 13. Gene Ther. 2015. PMID: 25394253

8

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

Verrier ER, Colpitts CC, Bach C, Heydmann L, Weiss A, Renaud M, Durand SC, Habersetzer F, Durantel D, Abou-Jaoudé G, López Ledesma MM, Felmlee DJ, Soumillon M, Croonenborghs T, Pochet N, Nassal M, Schuster C, Brino L, Sureau C, Zeisel MB, Baumert TF. Verrier ER, et al. Among authors: durand sc. Hepatology. 2016 Jan;63(1):35-48. doi: 10.1002/hep.28013. Epub 2015 Oct 6. Hepatology. 2016. PMID: 26224662

9

Use of a Closed Culture System to Improve the Safety of Lentiviral Vector Production.

Wu T, Bour G, Durand S, Lindner V, Gossé F, Zona L, Certoux JM, Diana M, Baumert TF, Marescaux J, Mutter D, Pessaux P, Robinet E. Wu T, et al. Hum Gene Ther Methods. 2015 Dec;26(6):197-210. doi: 10.1089/hgtb.2015.080. Epub 2015 Nov 10. Hum Gene Ther Methods. 2015. PMID: 26467420

10

Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma.

Wu T, Leboeuf C, Durand S, Su B, Deschamps M, Zhang X, Ferrand C, Pessaux P, Robinet E. Wu T, et al. Mol Med Rep. 2016 Mar;13(3):2645-54. doi: 10.3892/mmr.2016.4811. Epub 2016 Jan 27. Mol Med Rep. 2016. PMID: 26820174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters